RGM.20.010 – Beta cell replacement therapy for type 1 diabetes
Route: Regenerative medicine: game changer moving to broad areas of application
cluster question: 100 How can we use cells, stem cells, and biomaterials to engineer and regenerate tissues and organs?
Type 1 diabetes is a lifelong autoimmune disease which specifically destroys the insulin producing beta-cells residing in the pancreatic islets […]
View the initiative
PM.20.034 – Exploring the beta cell ligandome for type 1 diabetes diagnostic
Route: Personalised medicine: the individual at the centre
cluster question: 087 What causes type 1 and type 2 diabetes, how can we detect them sooner, and how can we treat them on an individual basis?
Diabetes currently affects 425 million people, with an estimated worldwide prevalence of 8%, and a further projected increase to 642 […]
View the initiative
